Table of Contents

• Catherine Kim,
• David F. Williamson,
• Carol M. Mangione,
• Monika M. Safford,
• Joseph V. Selby,
• David G. Marrero,
• J. David Curb,
• Theodore J. Thompson,
• K.M. Venkat Narayan,
• and William H. Herman

Managed Care Organization and the Quality of Diabetes Care: The Translating Research Into Action for Diabetes (TRIAD) study

• Jonathan B. Brown,
• Gregory A. Nichols,
• and Andrew Perry

The Burden of Treatment Failure in Type 2 Diabetes

• Andrew B. Muir,
• Ronald G. Quisling,
• Mark C.K. Yang,
• and Arlan L. Rosenbloom

Cerebral Edema in Childhood Diabetic Ketoacidosis: Natural history, radiographic findings, and early identification

• Theresa H.M. Keegan,
• Ann V. Schwartz,
• Douglas C. Bauer,
• Deborah E. Sellmeyer,
• and Jennifer L. Kelsey

Effect of Alendronate on Bone Mineral Density and Biochemical Markers of Bone Turnover in Type 2 Diabetic Women: The Fracture Intervention Trial

• Elizabeth A. Doyle (Boland),
• Stuart A. Weinzimer,
• Amy T. Steffen,
• Jo Ann H. Ahern,
• Miranda Vincent,
• and William V. Tamborlane

A Randomized, Prospective Trial Comparing the Efficacy of Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections Using Insulin Glargine

• Michael J. Mueller,
• David R. Sinacore,
• Mary Kent Hastings,
• Donovan J. Lott,
• Michael J Strube,
• and Jeffrey E. Johnson

Impact of Achilles Tendon Lengthening on Functional Limitations and Perceived Disability in People With a Neuropathic Plantar Ulcer

• Cristina Hernández and
• Rafael Simó

Albumin Excretion Rate Is Not Affected by Asymptomatic Urinary Tract Infection: A prospective study

• Anne M. Wolf,
• Mark R. Conaway,
• Jayne Q. Crowther,
• Kristen Y. Hazen,
• Jerry L.Nadler,
• Beverly Oneida,
• and Viktor E. Bovbjerg

Translating Lifestyle Intervention to Practice in Obese Patients With Type 2 Diabetes: Improving Control with Activity and Nutrition (ICAN) study

• Suzanne M. Strowig,
• M. Larissa Avilés-Santa,
• and Philip Raskin

Improved Glycemic Control Without Weight Gain Using Triple Therapy in Type 2 Diabetes

• Alfredo Ponce-de-Leon,
• Ma. de Lourdes Garcia-Garcia,
• Ma. Cecilia Garcia-Sancho,
• Francisco J. Gomez-Perez,
• Jose Luis Valdespino-Gomez,
• Gustavo Olaiz-Fernandez,
• Rosalba Rojas,
• Leticia Ferreyra-Reyes,
• Bulmaro Cano-Arellano,
• Miriam Bobadilla,
• Peter M. Small,
• and Jose Sifuentes-Osornio

Tuberculosis and Diabetes in Southern Mexico

• Edward W. Gregg,
• Paul Sorlie,
• Ryne Paulose-Ram,
• Qiuping Gu,
• Mark S. Eberhardt,
• Michael Wolz,
• Vicki Burt,
• Lester Curtin,
• Michael Engelgau,
• and Linda Geiss

Prevalence of Lower-Extremity Disease in the U.S. Adult Population ≥40 Years of Age With and Without Diabetes: 1999–2000 National Health and Nutrition Examination Survey

• Nicholas Tentolouris,
• Sameer Al-Sabbagh,
• Michael G. Walker,
• Andrew J.M. Boulton,
• and Edward B. Jude

Mortality in Diabetic and Nondiabetic Patients After Amputations Performed From 1990 to 1995: A 5-year follow-up study

• Chin-Hsiao Tseng

Mortality and Causes of Death in a National Sample of Diabetic Patients in Taiwan

• Michael G. Walsh,
• Janice Zgibor,
• Knut Borch-Johnsen,
• and Trevor J. Orchard

A Multinational Comparison of Complications Assessment in Type 1 Diabetes: The DiaMond Substudy of Complications (DiaComp) level 2

• Geir Joner,
• Lars C. Stene,
• and Oddmund Søvik

Nationwide, Prospective Registration of Type 1 Diabetes in Children Aged <15 Years in Norway 1989–1998: No increase but significant regional variation in incidence

• Anna Casu,
• Cristiana Pascutto,
• Luisa Bernardinelli,
• and Marco Songini

Type 1 Diabetes Among Sardinian Children Is Increasing: The Sardinian diabetes register for children aged 0–14 years (1989–1999)

• Yong-Fang Kuo,
• Mukaila A. Raji,
• M. Kristen Peek,
• and James S. Goodwin

Health-Related Social Disengagement in Elderly Diabetic Patients: Association with subsequent disability and survival

• Etta L. Fanning,
• Beatrice J. Selwyn,
• Anne C. Larme,
• and Ralph A. DeFronzo

Improving Efficacy of Diabetes Management Using Treatment Algorithms in a Mainly Hispanic Population

• Bernard Charbonnel,
• John Dormandy,
• Erland Erdmann,
• Massimo Massi-Benedetti,
• and Allan Skene

The Prospective Pioglitazone Clinical Trial in Macrovascular Events (PROactive): Can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5,238 patients

• Patricia Colton,
• Marion Olmsted,
• Denis Daneman,
• Anne Rydall,
• and Gary Rodin

Disturbed Eating Behavior and Eating Disorders in Preteen and Early Teenage Girls With Type 1 Diabetes: A case-controlled study

• Iwona Bogacka,
• Hui Xie,
• George A. Bray,
• and Steven R. Smith

The Effect of Pioglitazone on Peroxisome Proliferator-Activated Receptor-γ Target Genes Related to Lipid Storage In Vivo

• Carine H.M. van Schie,
• Cristiana Vermigli,
• Anne L. Carrington,
• and Andrew Boulton

Muscle Weakness and Foot Deformities in Diabetes: Relationship to neuropathy and foot ulceration in Caucasian diabetic men

• Lorne H. Zinman,
• Vera Bril,
• and Bruce A. Perkins

Cooling Detection Thresholds in the Assessment of Diabetic Sensory Polyneuropathy: Comparison of CASE IV and Medoc instruments

• Matthias B. Schulze,
• Eric B. Rimm,
• Iris Shai,
• Nader Rifai,
• and Frank B. Hu

Relationship Between Adiponectin and Glycemic Control, Blood Lipids, and Inflammatory Markers in Men With Type 2 Diabetes

• Alberto Francisco Rubio-Guerra,
• Adalberto Arceo-Navarro,
• German Vargas-Ayala,
• Leticia Rodriguez-Lopez,
• Jose Juan Lozano-Nuevo,
• and Carlos Treviño Gomez-Harper

The Effect of Trandolapril and Its Fixed-Dose Combination With Verapamil on Proteinuria in Normotensive Adults With Type 2 Diabetes

• Michael J. Theodorakis,
• Olga Carlson,
• Denis C. Muller,
• and Josephine M. Egan

Elevated Plasma Glucose-Dependent Insulinotropic Polypeptide Associates With Hyperinsulinemia in Impaired Glucose Tolerance

• Alice S. Ryan and
• Barbara J. Nicklas

Reductions in Plasma Cytokine Levels With Weight Loss Improve Insulin Sensitivity in Overweight and Obese Postmenopausal Women

• Jennifer L. Larsen,
• Christopher W. Colling,
• Tanaporn Ratanasuwan,
• Tab W. Burkman,
• Thomas G. Lynch,
• Judi M. Erickson,
• Elizabeth R. Lyden,
• James T. Lane,
• and Lynn R. Mack-Shipman

Pancreas Transplantation Improves Vascular Disease in Patients With Type 1 Diabetes

• Bobby V. Khan,
• Srikanth Sola,
• Wright B. Lauten,
• Rama Natarajan,
• W. Craig Hooper,
• Rekha G. Menon,
• Stamatios Lerakis,
• and Tarek Helmy

Quinapril, an ACE Inhibitor, Reduces Markers of Oxidative Stress in the Metabolic Syndrome

• Jay M. Sosenko,
• Martha Kato,
• and Ronald B. Goldberg

Sensory Function and Albumin Excretion According to Diagnostic Criteria for Diabetes

• Christine Winzer,
• Oswald Wagner,
• Andreas Festa,
• Barbara Schneider,
• Michael Roden,
• Dagmar Bancher-Todesca,
• Giovanni Pacini,
• Tohru Funahashi,
• and Alexandra Kautzky-Willer

Plasma Adiponectin, Insulin Sensitivity, and Subclinical Inflammation in Women With Prior Gestational Diabetes Mellitus

• E. Shyong Tai,
• Su Yen Goh,
• Jeannette J.M. Lee,
• Moh-Sim Wong,
• Derrick Heng,
• Kenneth Hughes,
• Suok Kai Chew,
• Jeffery Cutter,
• William Chew,
• Ken Gu,
• Kee Seng Chia,
• and Chee Eng Tan

Lowering the Criterion for Impaired Fasting Glucose: Impact on disease prevalence and associated risk of diabetes and ischemic heart disease

• Kalevi Pyörälä,
• Christie M. Ballantyne,
• Barry Gumbiner,
• Michael W. Lee,
• Arvind Shah,
• Michael J. Davies,
• Yale B. Mitchel,
• Terje R. Pedersen,
• and John Kjekshus

Reduction of Cardiovascular Events by Simvastatin in Nondiabetic Coronary Heart Disease Patients With and Without the Metabolic Syndrome: Subgroup analyses of the Scandinavian Simvastatin Survival Study (4S)

• Rajiv Roy,
• Maria Navar,
• Gladys Palomeno,
• and Mayer B. Davidson

Real World Effectiveness of Rosiglitazone Added to Maximal (Tolerated) Doses of Metformin and a Sulfonylurea Agent: A systematic evaluation of triple oral therapy in a minority population

• Michele Y.Y. Seah,
• Sadanand N. Anavekar,
• Judy A. Savige,
• and Louise M. Burrell

Diabetic Pyomyositis: An uncommon cause of a painful leg

• Ariane Sultan,
• Christophe Piot,
• Denis Mariano-Goulart,
• Manase Rasamisoa,
• Eric Renard,
• and Antoine Avignon

Risk Factors for Silent Myocardial Ischemia in High-Risk Type 1 Diabetic Patients

• Leonard E. Egede

Patterns and Correlates of Emergency Department Use by Individuals With Diabetes

• Leonard E. Egede

Effects of Depression on Work Loss and Disability Bed Days in Individuals With Diabetes

• Sonja K. Fredrickson,
• Thomas J. Ferro,
• and Andrew C. Schutrumpf

Disappearance of Microalbuminuria in a Patient With Type 2 Diabetes and the Metabolic Syndrome in the Setting of an Intense Exercise and Dietary Program With Sustained Weight Reduction

• Hisayo Yokoyama,
• Masanori Emoto,
• Takahiro Araki,
• Shigehiko Fujiwara,
• Koka Motoyama,
• Tomoaki Morioka,
• Hidenori Koyama,
• Tetsuo Shoji,
• Yasuhisa Okuno,
• and Yoshiki Nishizawa

Effect of Aerobic Exercise on Plasma Adiponectin Levels and Insulin Resistance in Type 2 Diabetes

• Lauren A. Plante

Low Birth Weight May Not Predict Diabetes in Pregnancy

• David E. Goldstein,
• Randie R. Little,
• Rodney A. Lorenz,
• John I. Malone,
• David Nathan,
• Charles M. Peterson,
• and David B. Sacks

Tests of Glycemia in Diabetes

• Matthew L. Maciejewski,
• Gayle E. Reiber,
• Douglas G. Smith,
• Carolyn Wallace,
• Shane Hayes,
• and Edward J. Boyko

Effectiveness of Diabetic Therapeutic Footwear in Preventing Reulceration

• Aaron Vinik,
• Anahit Mehrabyan,
• Lawrence Colen,
• and Andrew Boulton

Focal Entrapment Neuropathies in Diabetes

• Eugene J. Barrett and
• Carolé Mensing

The American Diabetes Association, the American Cancer Society, and the American Heart Association: A triumvirate of hope for the nation’s health

• Robert I. Misbin

The Phantom of Lactic Acidosis due to Metformin in Patients With Diabetes

• Michael S. Ip

Intravitreal Injection of Triamcinolone: An emerging treatment for diabetic macular edema

• George Alberti,
• Paul Zimmet,
• Jonathan Shaw,
• Zachary Bloomgarden,
• Francine Kaufman,
• and Martin Silink

Type 2 Diabetes in the Young: The Evolving Epidemic: The International Diabetes Federation Consensus Workshop

• Harmon Eyre,
• Richard Kahn,
• and Rose Marie Robertson

Preventing Cancer, Cardiovascular Disease, and Diabetes: A common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association

• Zachary T. Bloomgarden

Consequences of Diabetes: Cardiovascular disease

• Andrew J.M. Boulton and
• Edward B. Jude

Therapeutic Footwear in Diabetes: The good, the bad, and the ugly?

• Mayer B. Davidson

Triple Therapy: Definitions, application, and treating to target

• Christine P. Burren and
• Andrew T. Hattersley

Remitting Diabetes: A new genetic subgroup?

• Toshikatsu Shigihara,
• Akira Shimada,
• Yoshihumi Saisho,
• Toshihide Kawai,
• Hiroshi Maruyama,
• and Takao Saruta

Seroconversion of GAD Antibody in “Unclassified” Diabetes With Long Duration of Disease

• Nicolina Di Cosmo,
• Pietro Vajro,
• Dominique Debray,
• Giuliana Valerio,
• Michela Giugliano,
• Pietro Buono,
• and Adriana Franzese

Normal β-Cell Function in Post-Liver Transplantation Diabetes Treated With Tacrolimus

• Tetsuya Babazono,
• Chieko Takahashi,
• and Yasuhiko Iwamoto

Definition of Microalbuminuria in First-Morning and Random Spot Urine in Diabetic Patients

• Barry I. Joffe,
• Larry A. Distiller,
• and W. John Kalk

Lipid Levels in Black South Africans With Type 2 Diabetes: Dispelling misconceptions

• André J. Scheen and
• Fabian Warzée

Diabetes Is Still a Risk Factor for Restenosis After Drug-Eluting Stent in Coronary Arteries

• Andrea Morsanutto,
• Patrizia Berto,
• Stefania Lopatriello,
• Dario Voinovich,
• Renzo Gelisio,
• and Lorenzo G. Mantovani

Major Diabetes Complications Have an Impact on Total Annual Medical Cost of Type 2 Diabetes

• Etienne Larger,
• Benjamin Rakotoaminina,
• Mohammed Eddouks,
• José Timsit,
• Christian Boitard,
• Roger Assan,
• Rémy Burcelin,
• and Jean-Jacques Robert

Normal Insulin Sensitivity During the Late Preclinical Stage of Type 1 Diabetes

• Richard J. Stevens and
• Rury Holman

Comparative Study of Prognostic Value for Coronary Disease Risk Between the U.K. Prospective Diabetes Study and Framingham Models: Response to Protopsaltis et al.

• Ioannis D. Protopsaltis,
• George Nikolopoulos,
• and Andreas Melidonis

Comparative Study of Prognostic Value for Coronary Disease Risk Between the U.K. Prospective Diabetes Study and Framingham Models: Response to Stevens and Holman

• Fernando Granado-Lorencio and
• Begona Olmedilla-Alonso

Dietary Antioxidant Intake and Risk of Type 2 Diabetes: Response to Montonen et al.

• Jukka Montonen,
• Paul Knekt,
• Ritva Järvinen,
• and Antti Reunanen

Dietary Antioxidant Intake and Risk of Type 2 Diabetes: Response to Granado-Lorencio and Olmedilla-Alonso

• Mayer B. Davidson

Twice-Daily NPH or Mixture Insulins Versus Triple Therapy: Apples Versus Oranges: Response to Poulsen et al.

• Nasser Mikhail

The Combined Effect of Triple Therapy with Rosiglitazone, Metformin, and Insulin Aspart in Type 2 Diabetic Patients: Response to Poulsen et al.

• Henning Beck-Nielsen

The Combined Effect of Triple Therapy with Rosiglitazone, Metformin, and Insulin Aspart in Type 2 Diabetic Patients: Response to Davidson and Mikhail

• Stephanie A. Amiel and
• Maggie Blott

A Randomized Trial Evaluating a Predominantly Fetal Growth–Based Strategy to Guide Management of Gestational Diabetes in Caucasian Women: Response to Schaefer-Graf et al.

• Ute M. Schaefer-Graf

A Randomized Trial Evaluating a Predominantly Fetal Growth–Based Strategy to Guide Management of Gestational Diabetes in Caucasian Women: Response to Amiel and Blott

• Igor A. Harsch,
• Simin Pour Schahin,
• and Roderich Wiedmann

Multiple Symmetric Lipomatosis: A Paradigm of Metabolically Innocent Obesity?: Response to Haap et al.

• Michael Haap,
• Claus Thamer,
• Hans-Ulrich Häring,
• Rolf Markus Szeimies,
• and Michael Stumvoll

Multiple Symmetric Lipomatosis: A Paradigm of Metabolically Innocent Obesity?: Response to Harsch, Schahin, and Wiedmann

• Bo Berger,
• Pavel Burian,
• Kristina Nilsson,
• Mona Karlen,
• and Elisabeth Rylander

Has RoboCop Got Diabetes?

• Barry H. Ginsberg and
• Kenneth Strauss

Has RoboCop Got Diabetes?: Response to Berger et al.

Errata

Errata